- Home
- PB vs BLCO Comparison
PB vs BLCO Comparison
Compare PB & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PB
- BLCO
- Stock Information
- Founded
- PB 1983
- BLCO 1853
- Country
- PB United States
- BLCO Canada
- Employees
- PB N/A
- BLCO N/A
- Industry
- PB Major Banks
- BLCO Ophthalmic Goods
- Sector
- PB Finance
- BLCO Health Care
- Exchange
- PB Nasdaq
- BLCO Nasdaq
- Market Cap
- PB 7.2B
- BLCO 7.0B
- IPO Year
- PB 1998
- BLCO 2022
- Fundamental
- Price
- PB $74.94
- BLCO $18.02
- Analyst Decision
- PB Buy
- BLCO Buy
- Analyst Count
- PB 11
- BLCO 12
- Target Price
- PB $82.00
- BLCO $20.91
- AVG Volume (30 Days)
- PB 486.6K
- BLCO 524.8K
- Earning Date
- PB 01-22-2025
- BLCO 10-30-2024
- Dividend Yield
- PB 3.10%
- BLCO N/A
- EPS Growth
- PB N/A
- BLCO N/A
- EPS
- PB 4.69
- BLCO N/A
- Revenue
- PB $1,149,178,000.00
- BLCO $4,684,000,000.00
- Revenue This Year
- PB N/A
- BLCO $17.39
- Revenue Next Year
- PB $9.53
- BLCO $6.18
- P/E Ratio
- PB $15.97
- BLCO N/A
- Revenue Growth
- PB 3.39
- BLCO 18.01
- 52 Week Low
- PB $57.16
- BLCO $13.16
- 52 Week High
- PB $86.76
- BLCO $21.69
- Technical
- Relative Strength Index (RSI)
- PB 31.43
- BLCO 36.81
- Support Level
- PB $80.45
- BLCO $17.71
- Resistance Level
- PB $83.77
- BLCO $18.99
- Average True Range (ATR)
- PB 1.77
- BLCO 0.52
- MACD
- PB -1.18
- BLCO -0.17
- Stochastic Oscillator
- PB 13.78
- BLCO 10.17
About PB Prosperity Bancshares Inc.
Prosperity Bancshares Inc provides retail and commercial banking services to individuals and small to midsize businesses. It provides a wide array of financial products and services to businesses and consumers throughout Texas and Oklahoma.
About BLCO Bausch + Lomb Corporation
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.